The soft-tissue robotic-assisted surgery landscape is undergoing a structural realignment. For more than two decades,Intuitive Surgical maintained near-exclusive hegemony over general, urological, and gynecological robotic procedures through its da Vinci ecosystem. Over recent fiscal cycles, this market structure has been disrupted by fundamental shifts:key foundational patents have expired, hospital systems have faced mounting capital expenditure pressures, and surgical case

The European healthcare technology, medical devices (Medtech) and artificial intelligence (Health AI) ecosystems have transitioned from post-pandemic venture fragmentation into a disciplined era of industrial maturity. Following a severe liquidity drought that curtailed capital deployment and delayed public listings between late 2021 and 2024, the public offering window is reopening under fundamentally altered underwriting standards. Institutional public equity allocators no